drugset / Trial / NCT01557257
Pharmacokinetics Study of ALO-02 and OxyContin
RandomizedCrossoverOpen-labelBasic science
Summary
To characterize the single- and multiple-dose pharmacokinetics of oxycodone following the administration of ALO-02 40 Mg Twice Daily, ALO-02 80 Mg Once Daily or Oxycontin 40 Mg Twice Daily in Healthy Volunteers
Timeline
- Start
- 2012-03
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALO-02 | Unknown | 40 mg | — |
| Subject | ALO-02 | Unknown | 80 mg | — |
| Subject | Oxycodone | Other / unclassified | 40 mg | — |
| Background | Naltrexone | Small molecule | 50 mg | — |
Indications
No indication recorded.